Why TG Therapeutics Is Plunging More Than 40% Today

·2 min read
Why TG Therapeutics Is Plunging More Than 40% Today

Investors are rattled by the FDA's request for an out-of-the-ordinary meeting dedicated to scrutinizing the company's latest drug approval request.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting